03.21.25 -- Pharma's Guide To Making Health Communications Land Well

Discover how Dr. Kasper Roet’s work at the Dutch Brain Bank shaped his leadership at QurAlis, where three ALS clinical programs target specific genetic mechanisms. On Business of Biotech, co-host Ben Comer joins to explore QurAlis’ genetic medicine approach and Roet’s growing influence on regulatory reform. Hear how the FDA’s stance on genetic therapies is driving trials overseas—and why Roet is leading a biotech consortium to push for change. Tune in now!

By shifting from reactive problem-solving to proactive planning, predictive intelligence ensures trials meet their enrollment goals more efficiently.

As recombinant protein-based products accelerate toward IND, reliable process development methods are critical to meet demand. Review case studies to learn how expedited timelines can be achieved.

Embrace a broader approach to diversity in clinical trials by addressing social determinants of health and designing inclusive studies that ensure equitable representation and access to all patients.

Discover how 4,500 jobs were created across 16 communities and how North Carolina achieved a record-breaking year by securing over $10 billion in life sciences investments.

Discover highly promising in-vivo data, enabled by a nanoformed drug product, for the treatment of glioblastoma multiforme (GBM).